brexit-istock-537519806_andrewlinscott

andrewlinscott / iStockphoto.com

16 August 2019Big PharmaSaman Javed

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

Several pharma bodies have signed non-disclosure agreements (NDAs) which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More on this story

EMA settles Brexit dispute; issues drug shortages guidance

8 July 2019 The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

UK faces medicine shortages after no deal: leaked govt report

21 August 2019 A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

3 September 2019 Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service and lead to delays in new products being bought to market in the country, according to the British Medical Association.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent